ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Columbus, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Prostatic Cancer
Esophageal Cancer

Adenocarcinoma trials near Columbus, OH, USA:

Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma (PaTK02)

The purpose of this study is to characterize the safety, preliminary efficacy, and immune biologic activity of CAN-2409 + prodrug (valacyclovir or ac...

Active, not recruiting
Borderline Resectable Pancreatic Adenocarcinoma
Biological: Aglatimagene besadenovec
Procedure: Surgery

Phase 2

Candel Therapeutics

Columbus, Ohio, United States and 2 other locations

This is a single arm phase II study. All patients will receive 3 cycles of the treatment of nab-paclitaxel (Days 1, 8 and 15), gemcitabine (Days 1, 8...

Enrolling
Pancreatic Adenocarcinoma
Resectable Pancreatic Cancer
Drug: Gemcitabine
Device: NovoTTF-200T(P)

Phase 2

Ashish Manne

Columbus, Ohio, United States

participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...

Enrolling
Endometrial Adenocarcinoma
Urothelial Carcinoma
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

Hilliard, Ohio, United States and 67 other locations

first-line treatment of participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...

Active, not recruiting
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Drug: Domvanalimab
Drug: Zimberelimab

Phase 3

Arcus Biosciences
Arcus Biosciences

Columbus, Ohio, United States and 212 other locations

mCRPC. Patients enrolled in the Phase 2a portion of the study will have either Small Cell Neuroendocrine Prostate Cancer(SCNC)(Cohort A) or adenocarcinoma...

Active, not recruiting
Small Cell Carcinoma
Neuroendocrine Tumors
Drug: BXCL701 monotherapy
Drug: BXCL701 plus Pembrolizumab

Phase 1, Phase 2

BioXcel Therapeutics

Columbus, Ohio, United States and 11 other locations

unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. Why is this study being done? SPOTLIGHT is a new clinical st...

Active, not recruiting
Metastatic Gastric Adenocarcinoma or Cancer
Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Drug: fluorouracil
Drug: zolbetuximab

Phase 3

Astellas
Astellas

Columbus, Ohio, United States and 219 other locations

A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer

Enrolling
Pancreatic Adenocarcinoma
Metastatic
Genetic: VCN-01
Drug: Gemcitabine

Phase 2

Theriva Biologics

Columbus, Ohio, United States and 16 other locations

This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer age...

Enrolling
Lung Adenocarcinoma
Ovarian Cancer
Drug: AZD5305
Drug: AZD5335

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Columbus, Ohio, United States and 38 other locations

This is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without bu...

Enrolling
Pancreatic Cancer
Combination Product: TTX-030, budigalimab, nab-paclitaxel and gemcitabine
Combination Product: Nab-Paclitaxel and gemcitabine

Phase 2

Trishula Therapeutics

Columbus, Ohio, United States and 22 other locations

in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have received prior neoadjuva...

Enrolling
Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer Metastatic
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2, Phase 3

Panbela Therapeutics

Columbus, Ohio, United States and 91 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems